Package 68788-7781-1

{"route": ["ORAL"], "spl_id": "c2ed0d31-f724-4410-85b9-eb03eb7ab9bc", "openfda": {"unii": ["B53E3NMY5C"], "rxcui": ["313413"], "spl_set_id": ["32c3be66-5398-425c-ac65-e57ba819bb43"], "manufacturer_name": ["Preferred Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (68788-7781-1)", "package_ndc": "68788-7781-1", "marketing_start_date": "20200901"}, {"sample": false, "description": "20 TABLET in 1 BOTTLE (68788-7781-2)", "package_ndc": "68788-7781-2", "marketing_start_date": "20200901"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (68788-7781-3)", "package_ndc": "68788-7781-3", "marketing_start_date": "20200901"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (68788-7781-6)", "package_ndc": "68788-7781-6", "marketing_start_date": "20200901"}, {"sample": false, "description": "120 TABLET in 1 BOTTLE (68788-7781-8)", "package_ndc": "68788-7781-8", "marketing_start_date": "20200901"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (68788-7781-9)", "package_ndc": "68788-7781-9", "marketing_start_date": "20200901"}], "brand_name": "Tizanidine", "product_id": "68788-7781_c2ed0d31-f724-4410-85b9-eb03eb7ab9bc", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "68788-7781", "generic_name": "Tizanidine", "labeler_name": "Preferred Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tizanidine", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "4 mg/1"}], "application_number": "ANDA076286", "marketing_category": "ANDA", "marketing_start_date": "20200901", "listing_expiration_date": "20261231"}